Transmedics Group Stock Five Year Return

TMDX Stock

USD 69.05 0.21 0.31%

TransMedics Group fundamentals help investors to digest information that contributes to TransMedics' financial success or failures. It also enables traders to predict the movement of TransMedics Stock. The fundamental analysis module provides a way to measure TransMedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TransMedics stock.

Total Current Liabilities Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

TransMedics Group Company Five Year Return Analysis

TransMedics' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis

TransMedics Five Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for TransMedics is extremely important. It helps to project a fair market value of TransMedics Stock properly, considering its historical fundamentals such as Five Year Return. Since TransMedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TransMedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TransMedics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.8	0.82	-0.72	0.7	0.99	-0.45	0.96	0.99	0.68	0.91	0.99	0.97	0.74	0.61	0.8	0.97	-0.78	0.99	-0.12	-0.65	0.84	-0.74
Total Stockholder Equity	0.8		0.95	-0.77	0.48	0.73	-0.21	0.69	0.83	0.94	0.89	0.79	0.67	0.39	0.92	0.61	0.91	-0.59	0.86	0.36	-0.9	0.93	-0.56
Net Tangible Assets	0.82	0.95		-0.75	0.5	0.75	-0.14	0.71	0.86	0.89	0.9	0.79	0.69	0.38	0.81	0.57	0.89	-0.55	0.88	0.2	-0.93	0.96	-0.53
Retained Earnings	-0.72	-0.77	-0.75		-0.64	-0.65	0.06	-0.65	-0.77	-0.83	-0.81	-0.66	-0.61	-0.33	-0.79	-0.44	-0.79	0.44	-0.76	-0.28	0.79	-0.83	0.42
Accounts Payable	0.7	0.48	0.5	-0.64		0.75	-0.3	0.73	0.71	0.56	0.62	0.64	0.75	0.66	0.51	0.45	0.69	-0.28	0.69	0.0	-0.52	0.58	-0.24
Long Term Debt	0.99	0.73	0.75	-0.65	0.75		-0.48	0.98	0.97	0.62	0.85	0.97	0.99	0.82	0.56	0.78	0.94	-0.76	0.96	-0.14	-0.57	0.77	-0.72
Short Term Investments	-0.45	-0.21	-0.14	0.06	-0.3	-0.48		-0.52	-0.41	-0.1	-0.44	-0.5	-0.5	-0.24	-0.05	-0.38	-0.37	0.36	-0.42	0.5	-0.11	-0.25	0.35
Total Liab	0.96	0.69	0.71	-0.65	0.73	0.98	-0.52		0.94	0.58	0.84	0.95	0.97	0.8	0.52	0.76	0.92	-0.74	0.94	-0.17	-0.54	0.74	-0.71
Total Current Assets	0.99	0.83	0.86	-0.77	0.71	0.97	-0.41	0.94		0.74	0.93	0.96	0.95	0.68	0.66	0.73	0.98	-0.71	1.0	-0.09	-0.7	0.89	-0.68
Common Stock	0.68	0.94	0.89	-0.83	0.56	0.62	-0.1	0.58	0.74		0.82	0.64	0.56	0.27	0.97	0.44	0.82	-0.32	0.76	0.48	-0.94	0.92	-0.28
Property Plant Equipment	0.91	0.89	0.9	-0.81	0.62	0.85	-0.44	0.84	0.93	0.82		0.9	0.81	0.44	0.73	0.68	0.94	-0.66	0.94	0.0	-0.77	0.95	-0.63
Net Receivables	0.99	0.79	0.79	-0.66	0.64	0.97	-0.5	0.95	0.96	0.64	0.9		0.94	0.73	0.58	0.87	0.95	-0.85	0.96	-0.14	-0.59	0.81	-0.81
Current Deferred Revenue	0.97	0.67	0.69	-0.61	0.75	0.99	-0.5	0.97	0.95	0.56	0.81	0.94		0.85	0.5	0.73	0.91	-0.71	0.94	-0.19	-0.5	0.72	-0.68
Net Debt	0.74	0.39	0.38	-0.33	0.66	0.82	-0.24	0.8	0.68	0.27	0.44	0.73	0.85		0.3	0.66	0.67	-0.64	0.66	-0.06	-0.26	0.34	-0.61
Long Term Debt Total	0.61	0.92	0.81	-0.79	0.51	0.56	-0.05	0.52	0.66	0.97	0.73	0.58	0.5	0.3		0.43	0.78	-0.34	0.68	0.64	-0.89	0.82	-0.31
Capital Surpluse	0.8	0.61	0.57	-0.44	0.45	0.78	-0.38	0.76	0.73	0.44	0.68	0.87	0.73	0.66	0.43		0.75	-0.85	0.72	-0.11	-0.42	0.6	-0.78
Net Invested Capital	0.97	0.91	0.89	-0.79	0.69	0.94	-0.37	0.92	0.98	0.82	0.94	0.95	0.91	0.67	0.78	0.75		-0.73	0.98	0.1	-0.77	0.9	-0.69
Short Long Term Debt	-0.78	-0.59	-0.55	0.44	-0.28	-0.76	0.36	-0.74	-0.71	-0.32	-0.66	-0.85	-0.71	-0.64	-0.34	-0.85	-0.73		-0.7	0.11	0.33	-0.49	0.99
Net Working Capital	0.99	0.86	0.88	-0.76	0.69	0.96	-0.42	0.94	1.0	0.76	0.94	0.96	0.94	0.66	0.68	0.72	0.98	-0.7		-0.06	-0.73	0.9	-0.67
Short Term Debt	-0.12	0.36	0.2	-0.28	0.0	-0.14	0.5	-0.17	-0.09	0.48	0.0	-0.14	-0.19	-0.06	0.64	-0.11	0.1	0.11	-0.06		-0.47	0.13	0.1
Deferred Long Term Liab	-0.65	-0.9	-0.93	0.79	-0.52	-0.57	-0.11	-0.54	-0.7	-0.94	-0.77	-0.59	-0.5	-0.26	-0.89	-0.42	-0.77	0.33	-0.73	-0.47		-0.89	0.3
Capital Stock	0.84	0.93	0.96	-0.83	0.58	0.77	-0.25	0.74	0.89	0.92	0.95	0.81	0.72	0.34	0.82	0.6	0.9	-0.49	0.9	0.13	-0.89		-0.45
Intangible Assets	-0.74	-0.56	-0.53	0.42	-0.24	-0.72	0.35	-0.71	-0.68	-0.28	-0.63	-0.81	-0.68	-0.61	-0.31	-0.78	-0.69	0.99	-0.67	0.1	0.3	-0.45

Click cells to compare fundamentals

Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.

Competition

Predict TransMedics

TransMedics Return On Tangible Assets

Return On Tangible Assets

0.0471

At this time, TransMedics' Return On Tangible Assets are fairly stable compared to the past year.

According to the company disclosure, TransMedics Group has a Five Year Return of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

TransMedics Five Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TransMedics' direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TransMedics could also be used in its relative valuation, which is a method of valuing TransMedics by comparing valuation metrics of similar companies.

TransMedics is currently under evaluation in five year return category among its peers.

TransMedics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, TransMedics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to TransMedics' managers, analysts, and investors.

Environmental

Governance

Social

TransMedics Fundamentals

	Return On Equity	0.19
	Return On Asset	0.031
	Profit Margin	0.08 %
	Operating Margin	0.07 %
	Current Valuation	2.55 B
	Shares Outstanding	33.66 M
	Shares Owned By Insiders	3.49 %
	Shares Owned By Institutions	96.51 %
	Number Of Shares Shorted	10.76 M
	Price To Book	10.36 X
	Price To Sales	5.25 X
	Revenue	441.54 M
	Gross Profit	262.08 M
	EBITDA	69.95 M
	Net Income	35.46 M
	Cash And Equivalents	204.46 M
	Cash Per Share	6.41 X
	Total Debt	458.92 M
	Debt To Equity	0.36 %
	Current Ratio	12.11 X
	Book Value Per Share	6.80 X
	Cash Flow From Operations	48.8 M
	Short Ratio	6.26 X
	Earnings Per Share	1.07 X
	Target Price	102.86
	Number Of Employees	728
	Beta	2.12
	Market Capitalization	2.32 B
	Total Asset	804.08 M
	Retained Earnings	(468.24 M)
	Working Capital	437.3 M
	Net Asset	804.08 M

About TransMedics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze TransMedics Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TransMedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TransMedics Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC